News

At Digestive Disease Week, Paul Feuerstadt MD, FACG, AGAF and fellow investigators explore the potential impact of non-antibiotic medications on gut health and their association with recurrent CDI.

Both the World Health Organization and FDA have now recommended this particular set of viruses be left off influenza vaccines for the 2024-2025 respiratory virus season. A new study points to further evidence of their extinction.

Recent study sheds light on potential mechanisms underlying severe lung damage in COVID-19 patients.

A study shows the definitive presence of the virus long-term in individuals and could point to lingering symptoms and the possibility of Long COVID.

Regarding new-onset seizures in the general population, there was not a statistically significant variance in the risk of experiencing seizures between those who received the vaccine and those who got a placebo.

The program allows participants to reserve doses and be eligible for priority shipping, among other benefits.

Efforts among organizations aim to develop innovative vaccine candidates and advancements in the global fight against HIV.

Importance of thorough travel history assessment, consistent surveillance, and outreach efforts to manage malaria morbidity among travelers in the US.

This week, irrigation water in Utah creates E coli outbreak, FDA issues CRL for HEPLISAV-B 4 dose regimen, living with C diff awareness, and more this week from Contagion.

Hepatitis awareness remains essential to promote prevention and early detection, ensuring access to vaccination and treatment, and improving public health.

A new study demonstrates that for last year’s respiratory season, the difference in death rates were still much higher for COVID-19, but the gap closed significantly from the year before.

North Carolina’s senate voted to repeal the health exemption of the existing mask wearing law, thus disallowing any exceptions for people to wear a mask across the state.

Insights from virologist Erin Sorrell PhD MSc offer perspectives on prevention and response strategies.

Research indicates serum LOXL2 levels could serve as a predictor for hepatocellular carcinoma (HCC) risk in HCV patients who have achieved sustained virological response (SVR).

Insights from research on bloodstream infections with key attributions from study researcher Arden Baylink PhD.

Dennis Petragnani has battled gastrointestinal issues for years, and he shares what he sees as the transformation of change in the public and medical community talking about C diff and therapies around it, and the kinship with people he has met through the Peggy Lillis Foundation.

A large study on the future directions unveiling COVID-19 vaccine safety and risks.

The federal agency gave the nod to Roche’s human papillomavirus (HPV) self-collection and gives women the ability to gather their own sample in a health care setting, which can then be sent off for lab results.

SCORPIO-HR trial findings on ensitrelvir's role in managing COVID-19 amid regulatory hurdles.

The FDA announces the voluntary recall of Hy-Vee Cream Cheese Spread due to the potential contamination of Salmonella.

Dynavax is currently reviewing FDA feedback and strategizing a meeting to discuss their HEPLISAV-B 4-dose regimen for hemodialysis patients, determining the path forward toward approval.

Study examines the scarcity of data on the incidence of HBV-related hepatocellular carcinoma in West Africa.

On the day of a FDA PDUFA for a hepatitis B vaccine, it serves as reminder of great progress, but there remains a need to proliferate education especially around the liver.

From July to November 2021, cruise ships accommodating COVID-19-vaccinated individuals implemented almost identical nonpharmaceutical protocols.

In the second installment of the discussion around the Equity in Antimicrobial Stewardship Efforts (EASE), the codevelopers of this novel framework discuss how to move forward with interventions and measuring success around them.

During July–September 2023 the role of irrigation water in City A's E coli outbreak.

Antimicrobial stewardship to reduce multidrug resistance and opportunistic Clostridioides difficile infection (CDI) could also guide shorter treatment.

A comparative study presented MAD-ID, The Antimicrobial Stewardship Meeting examining the effectiveness of ceftaroline and vancomycin in addressing this challenge.

A study presented at The Annual Conference on Vaccinology Research (ACVR) offers insights into the efficacy of seasonal influenza vaccines.

The new Equity in Antimicrobial Stewardship Efforts (EASE) is a comprehensive set of priorities designed to overcome inequities and address the challenges with prescribing practices within the minoritized populations.